FILE PHOTO: A researcher works in a lab at the Duke-NUS Medical School, which is developing a way to track genetic changes that speed testing of vaccines against the coronavirus disease (COVID-19), in Singapore March 23, 2020. REUTERS/Joseph Campbell
LONDON/CHICAGO (Reuters) - It's dog eat dog in the world of COVID-19 vaccines.
That's the fear of global health agencies planning a scheme to bulk-buy and equitably distribute vaccines around the world. They are watching with dismay as some wealthier countries have decided to go it alone, striking deals with drugmakers to secure millions of doses of promising candidates for their citizens.
Already a subscriber? Log in.
Get 30% off with our ads free Premium Plan!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
